Wordt geladen...
Novel Oral Anticoagulants Versus Warfarin Therapy at Various Levels of Anticoagulation Control in Atrial Fibrillation—A Cost-Effectiveness Analysis
BACKGROUND: The decision as to whether to use more expensive novel oral anticoagulants (NOACs) or invest resources for quality improvement of warfarin therapy requires input from both clinical and economic analyses. OBJECTIVE: Cost-effectiveness of NOACs compared to warfarin therapy at various level...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer US
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3930767/ https://ncbi.nlm.nih.gov/pubmed/24132628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-013-2639-2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|